Your browser doesn't support javascript.
loading
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.
Tabatabaeepour, Nadia; Morgan, Jake R; Jalali, Ali; Kapadia, Shashi N; Meinhofer, Angélica.
Affiliation
  • Tabatabaeepour N; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
  • Morgan JR; Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, United States.
  • Jalali A; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
  • Kapadia SN; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
  • Meinhofer A; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States. Electronic address: anm4001@med.cornell.edu.
J Subst Abuse Treat ; 140: 108800, 2022 09.
Article in En | MEDLINE | ID: mdl-35577664
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Opiate Overdose / Opioid-Related Disorders Type of study: Prognostic_studies Limits: Female / Humans / Pregnancy Language: En Journal: J Subst Abuse Treat Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Opiate Overdose / Opioid-Related Disorders Type of study: Prognostic_studies Limits: Female / Humans / Pregnancy Language: En Journal: J Subst Abuse Treat Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos